JASON D MATHEWS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MATTOON, IL NPI 1760922397
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner IL Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$519.41
- Category: General Payments
- Program years: PY2021–2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $125.76 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $125.76 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $40.20 | 2 |
| ABBVIE INC. | $18.61 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.40 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.26 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.30 | 1 |
| Gilead Sciences, Inc. | $14.99 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078010006 | Janssen Pharmaceuticals, Inc | $16.72 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078010048 | Janssen Pharmaceuticals, Inc | $23.48 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087021936 | Novartis Pharmaceuticals Corporation | $18.26 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107606869 | ABBVIE INC. | $18.61 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119131716 | Otsuka America Pharmaceutical, Inc. | $15.30 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133708127 | Gilead Sciences, Inc. | $14.99 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153426484 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.40 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.